Access to anti-retroviral drugs, male in Pakistan

Pakistan: Access to anti-retroviral drugs, male was 14.0% in 2024. ◆ Volatile

Latest (2024)
14.0%
Change on year
up 16.7%
World rank
140th
of 141 countries
All-time high
14.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Pakistan, 2000–2024

0510152000201220242000: 0 %2001: 0 %2002: 2 %2003: 2 %2004: 1 %2005: 0 %2006: 0 %2007: 1 %2008: 1 %2009: 2 %2010: 2 %2011: 2 %2012: 2 %2013: 2 %2014: 3 %2015: 4 %2016: 5 %2017: 6 %2018: 8 %2019: 10 %2020: 9 %2021: 8 %2022: 10 %2023: 12 %2024: 14 %

Source: UNAIDS estimates. Measured in %.

Analysis

In 2024, access to anti-retroviral drugs, male in Pakistan stood at 14.0%. That is the highest value across all 25 years on record.

The figure is up 16.7% on the previous year and up 366.7% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Pakistan peaked at 14.0% in 2024 and was at its lowest, 0.0%, in 2000.

That places Pakistan 140th out of 141 countries with data for 2024, putting it in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Pakistan, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Pakistan, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 2.0%
2003 2.0% +0.0%
2004 1.0% -50.0%
2005 0.0% -100.0%
2006 0.0%
2007 1.0%
2008 1.0% +0.0%
2009 2.0% +100.0%
2010 2.0% +0.0%
2011 2.0% +0.0%
2012 2.0% +0.0%
2013 2.0% +0.0%
2014 3.0% +50.0%
2015 4.0% +33.3%
2016 5.0% +25.0%
2017 6.0% +20.0%
2018 8.0% +33.3%
2019 10.0% +25.0%
2020 9.0% -10.0%
2021 8.0% -11.1%
2022 10.0% +25.0%
2023 12.0% +20.0%
2024 14.0% +16.7%

Averages by decade

DecadeAverage LowestHighest Years
2000s 0.9% 0.0% 2.0% 10
2010s 4.4% 2.0% 10.0% 10
2020s 10.6% 8.0% 14.0% 5

Countries ranked near Pakistan

  1. 138 Sudan 23.0% compare
  2. 139 Madagascar 22.0% compare
  3. 141 Afghanistan 7.0% compare

See the full ranking of 160 places →

More gender data for Pakistan

All data for Pakistan →

Frequently asked questions

What is access to anti-retroviral drugs, male in Pakistan?
Access to anti-retroviral drugs, male in Pakistan was 14.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Pakistan?
The highest recorded value was 14.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Pakistan?
The lowest recorded value was 0.0% in 2000.
How does Pakistan rank for access to anti-retroviral drugs, male?
Pakistan ranks 140th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Pakistan?
Over the last ten years it is up 366.7%. The long-run trend across the full record is volatile.
Where does this Pakistan data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Pakistan. Statizoid, drawing on UNAIDS estimates. Retrieved 12 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/pakistan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/pakistan/">Access to anti-retroviral drugs, male in Pakistan</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.